We are live on ! Find out more
SCM

Suffolk Capital Management Portfolio holdings

AUM $521M
1-Year Est. Return 9.79%
This Fund
S&P 500
This Quarter Est. Return
+2.85%
1 Year Est. Return
-9.79%
3 Year Est. Return
+48.57%
5 Year Est. Return
+94.78%
10 Year Est. Return
AUM
$841M
AUM Growth
-$11.9M
Cap. Flow
-$27.5M
Cap. Flow %
-3.27%
Top 10 Hldgs %
20.85%
Holding
159
New
21
Increased
47
Reduced
62
Closed
27

Top Buys

Rank Stock Value
1
LOW icon
Lowe's Companies
LOW
+$13.8M
2
MA icon
Mastercard
MA
+$13.6M
3
VIAB
Viacom Inc. Class B
VIAB
+$13.4M
4
XYL icon
Xylem
XYL
+$13M
5
DD icon
DuPont de Nemours
DD
+$12M

Top Sells

Rank Stock Value
1
CLVS
Clovis Oncology, Inc.
CLVS
+$13.9M
2
YHOO
Yahoo Inc
YHOO
+$13.6M
3
ADBE icon
Adobe
ADBE
+$13.6M
4
HUM icon
Humana
HUM
+$12.5M
5
GM icon
General Motors
GM
+$11.9M

Sector Composition

Rank Sector Weight
1 Healthcare 18.9%
2 Technology 17.04%
3 Financials 13.84%
4 Industrials 13.66%
5 Communication Services 10.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BWLD
101
DELISTED
Buffalo Wild Wings, Inc.
BWLD
$2.64M 0.31%
16,861
+3,156
+23% +$516K
TMH
102
DELISTED
Team Health Holdings Inc
TMH
$2.63M 0.31%
40,227
-5,541
-12% -$335K
MPAA icon
103
Motorcar Parts of America
MPAA
$260M
$2.58M 0.31%
85,919
-38,188
-31% -$1.12M
SRCI
104
DELISTED
SRC Energy Inc
SRCI
$2.58M 0.31%
225,889
+54,589
+32% +$656K
OZK icon
105
Bank OZK
OZK
$5.57B
$2.58M 0.31%
56,336
-16,086
-22% -$684K
SAM icon
106
Boston Beer
SAM
$1.93B
$2.56M 0.3%
+11,045
New +$2.84M
FOE
107
DELISTED
Ferro Corporation
FOE
$2.53M 0.3%
150,590
-16,696
-10% -$242K
CLDX icon
108
Celldex Therapeutics
CLDX
$3.02B
$2.48M 0.3%
6,565
+1,361
+26% +$540K
LGND icon
109
Ligand Pharmaceuticals
LGND
$5.94B
$2.48M 0.29%
39,384
-28,713
-42% -$1.57M
ABUS icon
110
Arbutus Biopharma
ABUS
$871M
$2.46M 0.29%
207,417
+89,317
+76% +$1.36M
TLGT
111
DELISTED
Teligent, Inc
TLGT
$2.45M 0.29%
38,879
+8,386
+28% +$567K
BDC icon
112
Belden
BDC
$4.56B
$2.44M 0.29%
30,052
-5,520
-16% -$484K
CY
113
DELISTED
Cypress Semiconductor
CY
$2.4M 0.29%
204,474
-11,464
-5% -$151K
HUBG icon
114
HUB Group
HUBG
$2.78B
$2.31M 0.27%
114,346
-31,070
-21% -$635K
SGMO
115
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$2.19M 0.26%
+197,000
New +$2.54M
ASC icon
116
Ardmore Shipping
ASC
$703M
$2.12M 0.25%
175,421
-15,557
-8% -$182K
STNG icon
117
Scorpio Tankers
STNG
$3.76B
$2.11M 0.25%
20,938
-7,200
-26% -$691K
TSRO
118
DELISTED
TESARO, Inc.
TSRO
$1.96M 0.23%
33,269
-16,138
-33% -$926K
IMPV
119
DELISTED
Imperva, Inc.
IMPV
$1.93M 0.23%
28,527
-14,084
-33% -$777K
PBH icon
120
Prestige Consumer Healthcare
PBH
$2.37B
$1.89M 0.22%
40,834
-27,400
-40% -$1.2M
FARO
121
DELISTED
Faro Technologies
FARO
$1.86M 0.22%
39,888
-1,478
-4% -$69.5K
FANG icon
122
Diamondback Energy
FANG
$56.2B
$1.77M 0.21%
23,536
-13,940
-37% -$1.11M
WMGI
123
DELISTED
Wright Medical Group Inc
WMGI
$1.74M 0.21%
66,346
-51,500
-44% -$1.36M
BLUE
124
DELISTED
bluebird bio
BLUE
$1.37M 0.16%
626
-595
-49% -$1.21M
CPHD
125
DELISTED
Cepheid Inc
CPHD
$1.33M 0.16%
+21,800
New +$1.24M

Similar funds

Suffolk Capital Management's Q2 2015 Portfolio in Review

As of Q2 2015, Suffolk Capital Management held 159 positions worth $841M, down 1.4% from $853M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Suffolk Capital Management withdrew a net $27.5M in Q2 2015, closing 27 positions and reducing 62 holdings. Its most notable exit was Clovis Oncology, Inc., an estimated $13.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 24% a quarter earlier, followed by Technology and Financials.

Against the trend, Suffolk Capital Management opened a new position in Lowe's Companies worth $13M.

  • Suffolk Capital Management's largest Q2 2015 buy was Lowe's Companies: 193,964 shares worth $13M.
  • Suffolk Capital Management added most to RECEPTOS INC COM STK (DE) in Q2 2015, an estimated $7.8M increase.
  • Suffolk Capital Management's biggest Q2 2015 reduction was RTX Corp, cutting an estimated $10.1M.
  • Suffolk Capital Management fully exited Clovis Oncology, Inc. in Q2 2015, selling an estimated $13.9M.
  • Suffolk Capital Management's ten largest holdings make up 21% of its $841M portfolio in Q2 2015.
  • Suffolk Capital Management opened 21 new positions and closed 27 in Q2 2015.
  • Suffolk Capital Management's portfolio value fell 1.4% quarter-over-quarter to $841M.

Based on Suffolk Capital Management's 13F filing for Q2 2015, filed 12 Aug 2015.